• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TREM2 在阿尔茨海默病中的作用。

TREM2 in Alzheimer's disease.

机构信息

Department of Neurology, Qingdao Municipal Hospital, Nanjing Medical University, Nanjing, China.

出版信息

Mol Neurobiol. 2013 Aug;48(1):180-5. doi: 10.1007/s12035-013-8424-8. Epub 2013 Feb 14.

DOI:10.1007/s12035-013-8424-8
PMID:23407992
Abstract

Recent works have demonstrated a rare functional variant (R47H) in triggering receptor expressed on myeloid cells (TREM) 2 gene, encoding TREM2 protein, increase susceptibility to late-onset Alzheimer's disease (AD), with an odds ratio similar to that of the apolipoprotein E ε4 allele. The reduced function of TREM2 was speculated to be the main cause in the pathogenic effects of this risk variant, and TREM2 is highly expressed in white matter, as well as in the hippocampus and neocortex, which is partly consistent with the pathological features reported in AD brain, indicating the possible involvement of TREM2 in AD pathogenesis. Emerging evidence has demonstrated that TREM2 could suppress inflammatory response by repression of microglia-mediated cytokine production and secretion, which may prevent inflammation-induced bystander damage of neurons. TREM2 also participates in the regulation of phagocytic pathways that are responsible for the removal of neuronal debris. In this article, we review the recent epidemiological findings of TREM2 that related with late-onset AD and speculate the possible roles of TREM2 in progression of this disease. Based on the potential protective actions of TREM2 in AD pathogenesis, targeting TREM2 might provide new opportunities for AD treatment.

摘要

最近的研究工作表明,髓样细胞表达的触发受体(TREM)2 基因中存在一种罕见的功能变异(R47H),该基因编码 TREM2 蛋白,增加了晚发性阿尔茨海默病(AD)的易感性,其优势比类似于载脂蛋白 E ε4 等位基因。推测 TREM2 的功能降低是该风险变异体致病作用的主要原因,TREM2 在白质以及海马体和新皮层中高度表达,这与 AD 大脑中报道的部分病理特征部分一致,表明 TREM2 可能参与 AD 的发病机制。新出现的证据表明,TREM2 可以通过抑制小胶质细胞介导的细胞因子产生和分泌来抑制炎症反应,从而防止神经元炎症引起的旁观者损伤。TREM2 还参与负责清除神经元碎片的吞噬途径的调节。在本文中,我们回顾了 TREM2 与晚发性 AD 相关的最新流行病学研究结果,并推测了 TREM2 在该疾病进展中的可能作用。基于 TREM2 在 AD 发病机制中的潜在保护作用,靶向 TREM2 可能为 AD 的治疗提供新的机会。

相似文献

1
TREM2 in Alzheimer's disease.TREM2 在阿尔茨海默病中的作用。
Mol Neurobiol. 2013 Aug;48(1):180-5. doi: 10.1007/s12035-013-8424-8. Epub 2013 Feb 14.
2
R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.TREM2的R47H变异体与一个大型晚发型家族中的阿尔茨海默病相关:临床、遗传和神经病理学研究
JAMA Neurol. 2015 Aug;72(8):920-7. doi: 10.1001/jamaneurol.2015.0979.
3
TREM2 and the Progression of Alzheimer's Disease.触发受体表达于髓样细胞2(TREM2)与阿尔茨海默病的进展
Curr Neurovasc Res. 2017;14(2):177-183. doi: 10.2174/1567202614666170404165201.
4
TREM2 and the neuroimmunology of Alzheimer's disease.TREM2 与阿尔茨海默病的神经免疫。
Biochem Pharmacol. 2014 Apr 15;88(4):495-8. doi: 10.1016/j.bcp.2013.11.021. Epub 2013 Dec 16.
5
TREM2 regulates innate immunity in Alzheimer's disease.TREM2 调节阿尔茨海默病中的固有免疫。
J Neuroinflammation. 2018 Apr 14;15(1):107. doi: 10.1186/s12974-018-1148-y.
6
Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.阿尔茨海默病大脑中野生型和p.R47H TREM2变体的表达及加工分析
Mol Neurodegener. 2016 Nov 25;11(1):72. doi: 10.1186/s13024-016-0137-9.
7
The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans.Trem2 R47H 阿尔茨海默病风险变异体可损害剪接,并降低小鼠而非人类的 Trem2 mRNA 和蛋白。
Mol Neurodegener. 2018 Sep 6;13(1):49. doi: 10.1186/s13024-018-0280-6.
8
Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation.髓系细胞表达的触发受体2和小胶质细胞中类似髓系细胞表达的触发受体转录本2在小胶质细胞激活中的相反作用。
Neurobiol Aging. 2016 Jun;42:132-41. doi: 10.1016/j.neurobiolaging.2016.03.004. Epub 2016 Mar 16.
9
IPSC-Derived Neuronal Cultures Carrying the Alzheimer's Disease Associated R47H Variant Enables the Construction of an Aβ-Induced Gene Regulatory Network.携带阿尔茨海默病相关 R47H 变异的 IPSC 衍生神经元培养物可构建 Aβ 诱导的基因调控网络。
Int J Mol Sci. 2020 Jun 25;21(12):4516. doi: 10.3390/ijms21124516.
10
The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease.Trem2 R47H 变异体在阿尔茨海默病中表现出类似功能丧失的表型。
Mol Neurodegener. 2018 Jun 1;13(1):29. doi: 10.1186/s13024-018-0262-8.

引用本文的文献

1
in Neurodegenerative Disorders: Mutation Spectrum, Pathophysiology, and Therapeutic Targeting.《神经退行性疾病:突变谱、病理生理学及治疗靶点》
Int J Mol Sci. 2025 Jul 22;26(15):7057. doi: 10.3390/ijms26157057.
2
Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer's Disease.白藜芦醇可减轻阿尔茨海默病患者神经退行性变和神经炎症的脑脊液标志物水平。
Int J Mol Sci. 2025 May 23;26(11):5044. doi: 10.3390/ijms26115044.
3
Dehydroervatamine as a promising novel TREM2 agonist, attenuates neuroinflammation.

本文引用的文献

1
TREM2: a new risk factor for Alzheimer's disease.触发受体表达于髓细胞2:阿尔茨海默病的一个新风险因素。
Clin Genet. 2013 Jun;83(6):525-6. doi: 10.1111/cge.12108.
2
Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement.应用外显子组测序揭示 TREM2 突变导致的额颞叶痴呆样综合征而无骨骼累及。
JAMA Neurol. 2013 Jan;70(1):78-84. doi: 10.1001/jamaneurol.2013.579.
3
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice.NLRP3 在阿尔茨海默病中被激活,并促进 APP/PS1 小鼠的病变。
脱氢艾文碱作为一种有前景的新型触发受体表达于髓样细胞2(TREM2)激动剂,可减轻神经炎症。
Neurotherapeutics. 2025 Mar;22(2):e00479. doi: 10.1016/j.neurot.2024.e00479. Epub 2024 Nov 28.
4
Alzheimer's Disease and Vascular Dementia, Connecting and Differentiating Features.阿尔茨海默病与血管性痴呆:联系与鉴别特征
Curr Alzheimer Res. 2024 Jul 29. doi: 10.2174/0115672050319219240711103459.
5
Study on pyroptosis-related genes Casp8, Gsdmd and Trem2 in mice with cerebral infarction.脑梗死小鼠中与细胞焦亡相关基因 Casp8、Gsdmd 和 Trem2 的研究
PeerJ. 2024 Feb 9;12:e16818. doi: 10.7717/peerj.16818. eCollection 2024.
6
Hotspots and trends of microglia in Alzheimer's disease: a bibliometric analysis during 2000-2022.阿尔茨海默病中小胶质细胞的热点和趋势:2000-2022 年的文献计量分析。
Eur J Med Res. 2024 Jan 24;29(1):75. doi: 10.1186/s40001-023-01602-9.
7
Mechanistic insights into the role of herpes simplex virus 1 in Alzheimer's disease.对单纯疱疹病毒1型在阿尔茨海默病中作用的机制性见解。
Front Aging Neurosci. 2023 Sep 7;15:1245904. doi: 10.3389/fnagi.2023.1245904. eCollection 2023.
8
The H157Y Variant Influences Microglial Phagocytosis, Polarization, and Inflammatory Cytokine Release.H157Y变异体影响小胶质细胞的吞噬作用、极化和炎性细胞因子释放。
Brain Sci. 2023 Apr 9;13(4):642. doi: 10.3390/brainsci13040642.
9
The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer's Disease: New Potential Treatment Target.JAK/STAT 信号通路在阿尔茨海默病发病机制中的作用:新的潜在治疗靶点。
Int J Mol Sci. 2023 Jan 3;24(1):864. doi: 10.3390/ijms24010864.
10
Anesthesia and surgery-induced elevation of CSF sTREM2 is associated with early cognitive dysfunction after thoracoabdominal aortic dissection surgery.麻醉和手术引起的 CSF sTREM2 升高与胸腹主动脉夹层手术后早期认知功能障碍有关。
BMC Anesthesiol. 2022 Dec 31;22(1):413. doi: 10.1186/s12871-022-01955-4.
Nature. 2013 Jan 31;493(7434):674-8. doi: 10.1038/nature11729. Epub 2012 Dec 19.
4
Alzheimer disease: TREM2 linked to late-onset AD.阿尔茨海默病:TREM2与晚发性阿尔茨海默病相关。
Nat Rev Neurol. 2013 Jan;9(1):5. doi: 10.1038/nrneurol.2012.254. Epub 2012 Dec 4.
5
Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline.抑制白细胞介素 12/23 信号通路可减轻阿尔茨海默病样病理和认知功能减退。
Nat Med. 2012 Dec;18(12):1812-9. doi: 10.1038/nm.2965. Epub 2012 Nov 25.
6
Variant TREM2 as risk factor for Alzheimer's disease.TREM2基因变异作为阿尔茨海默病的风险因素。
N Engl J Med. 2013 Jan 10;368(2):182-4. doi: 10.1056/NEJMe1213157. Epub 2012 Nov 14.
7
TREM2 variants in Alzheimer's disease.TREM2 变体在阿尔茨海默病中的作用。
N Engl J Med. 2013 Jan 10;368(2):117-27. doi: 10.1056/NEJMoa1211851. Epub 2012 Nov 14.
8
Variant of TREM2 associated with the risk of Alzheimer's disease.与阿尔茨海默病风险相关的 Trem2 变异。
N Engl J Med. 2013 Jan 10;368(2):107-16. doi: 10.1056/NEJMoa1211103. Epub 2012 Nov 14.
9
The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.阿尔茨海默病脑中神经退行性变和再生中小胶质细胞激活表型的分类。
Arch Immunol Ther Exp (Warsz). 2012 Aug;60(4):251-66. doi: 10.1007/s00005-012-0181-2. Epub 2012 Jun 19.
10
TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells.TREM-2,髓系细胞触发受体-2,负向调节树突状细胞中的 TLR 反应。
Eur J Immunol. 2012 Jan;42(1):176-85. doi: 10.1002/eji.201141679. Epub 2011 Dec 12.